Table 3.
Group | ID | |||
---|---|---|---|---|
N | n | Prevalence, % (95% CI) | PR (95% CI) | |
Total | ||||
NPW in fertile agea | 3500 | 2553 | 72.9 (71.4–74.4) | 1 (reference) |
Pregnant women | 1125 | 1066 | 94.8 (93.3–96.0) | 1.30 (1.27–1.33)∗∗∗ |
1st trimester | 41 | 36 | 87.8 (73.8–95.9) | 1.20 (1.07–1.35)∗∗ |
2nd trimester | 633 | 588 | 92.9 (90.6–94.8) | 1.27 (1.24–1.31)∗∗∗ |
3rd trimester | 451 | 442 | 98.0 (96.2–99.1) | 1.34 (1.31–1.38)∗∗∗ |
| ||||
18–26 years | 3 | |||
NPW in fertile agea | 870 | 679 | 78.0 (75.1–80.8) | 1 (reference) |
Pregnant women | 203 | 195 | 96.1 (92.4–98.3) | 1.23 (1.18–1.29)∗∗∗ |
1st trimester | 10 | 10 | 100 (69.2–100) | 1.28 (1.24–1.33)∗∗∗ |
2nd trimester | 117 | 110 | 94.0 (88.1–97.6) | 1.21(1.14–1.28)∗∗∗ |
3rd trimester | 76 | 75 | 98.7 (92.9–100) | 1.26 (1.21–1.32)∗∗∗ |
| ||||
27–35 years | ||||
NPW in fertile agea | 1285 | 932 | 72.5 (70.0–75.0) | 1 (reference) |
Pregnant women | 723 | 682 | 94.3 (92.4–95.9) | 1.30 (1.25–1.35)∗∗∗ |
1st trimester | 23 | 19 | 82.6 (61.2–95.0) | 1.14 (0.94–1.38) |
2nd trimester | 414 | 383 | 92.5 (89.5–94.9) | 1.28 (1.22–1.33)∗∗∗ |
3rd trimester | 286 | 280 | 97.9 (95.5–99.2) | 1.35 (1.30–1.40)∗∗∗ |
| ||||
36–44 years | ||||
NPW in fertile agea | 1345 | 942 | 70.0 (67.5–72.5) | 1 (reference) |
Pregnant women | 199 | 189 | 95.0 (91.0–97.6) | 1.36 (1.30–1.42)∗∗∗ |
1st trimester | 8 | 7 | 87.5 (47.3–99.7) | 1.25 (0.96–1.63) |
2nd trimester | 102 | 95 | 93.1 (86.4–97.2) | 1.33 (1.25–1.42)∗∗∗ |
3rd trimester | 89 | 87 | 97.8 (92.1–99.7) | 1.40 (1.33–1.46)∗∗∗ |
CI; confidence interval; ID, iron deficiency; N, total number of participants; n, number of participants with iron deficiency; NPW, nonpregnant women; PR, prevalence ratio. aSubgroups of nonpregnant women matched to the same age groups of the pregnant women. ∗∗p value <0.01, ∗∗∗p value <0.001; Wald chi-square test. Nonpregnant women ≤51 years versus >51 years.